Data from the University of Bristol's Children of the 90s study were used in the research.

In every single state, researchers expect at least 35% of adults to have a body mass index of 30 or higher, the threshold ...

Pfizer Inc. is drawing on lessons learned years ago from rolling out Viagra as it maps out the launch of its first obesity medicine.

AUSTIN, TX, UNITED STATES, January 27, 2026 /EINPresswire.com/ -- Omnia Health Solutions, LLC (“Omnia”), a real-world ...

Having a high body mass index (BMI) as a young child may not reflect a lifelong risk of obesity, researchers suggest. A study by experts in Australia found the genetic factors that influence the size ...

Clinicians warn that GLP-1 treatment often ends within a year and can lead to rapid weight regain; experts urge personalized nutrition, behavioral care, and continued research.

A public health expert explains how GLP-1 drugs have changed the way healthcare providers understand and treat obesity.

A global study shows obesity heightens the risk of severe infections and related deaths across multiple disease types and ...

It turns out your mouth may know more about your metabolism than your bathroom scale. New research shows that people with ...

Research shows that metabolic surgery and GLP-1 medications are both effective therapies for treating obesity. Medications ...

With their blockbuster obesity drugs, Eli Lilly and Novo Nordisk have uncovered a variety of ailments the incretin treatments can combat. | Six weeks after Eli Lilly revealed the success of phase 3b ...

Eli Lilly and Company (NYSE: LLY) is one of the best growth stocks to buy for the next 20 years. On February 18, Eli Lilly ...